Macular Degeneration Association

Therapeutic Areas: Oncology | Dermatology | Family Medicine

Squamous Cell Carcinoma Clinical Trials

A listing of Squamous Cell Carcinoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Tuscaloosa Alabama 35401

A clinical study for patients with Basal Cell Carcinoma or Squamous Cell Carcinoma

Arizona

Casa Grande Arizona 85222

A clinical study for patients with Basal Cell Carcinoma or Squamous Cell Carcinoma

Scottsdale Arizona 85251

A clinical study for patients with Basal Cell Carcinoma or Squamous Cell Carcinoma

Tucson Arizona 85715

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

California

Duarte California 91010

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Los Angeles California 90095

A clinical trial to evaluate treatments using MGA271 for patients

Los Angeles California 90033

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Pleasant Hill California 94523

A clinical study for patients with Basal Cell Carcinoma or Squamous Cell Carcinoma

Santa Rosa California 95403

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Stanford California 94305

A clinical trial to evaluate treatments using TH-4000 for patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin (SCCHN or SCCS)

Colorado

Aurora Colorado 80045

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Connecticut

New Haven Connecticut 06510

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

District of Columbia

Washington District of Columbia 20007

A clinical research study of Nilotinib + Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Washington District of Columbia 20007

A clinical trial to evaluate treatments using TH-4000 for patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin (SCCHN or SCCS)

Florida

Miami Florida 33136

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Tampa Florida 33612

A clinical trial to evaluate treatments using MGA271 for patients

Tampa Florida 33612

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Illinois

Chicago Illinois 60637

A clinical trial to evaluate treatments using MGA271 for patients

Chicago Illinois 60611

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Indiana

Lafayette Indiana

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Maryland

Baltimore Maryland 21201

Patients are needed to participate in a clinical research study evaluating Reirradiation and MK-3475 for the treatment of Recurrent Head and Neck Cancer or Carcinoma, Squamous Cell of Head and Neck

Baltimore Maryland 21287

Patients are needed to participate in a clinical research study evaluating Reirradiation and MK-3475 for the treatment of Recurrent Head and Neck Cancer or Carcinoma, Squamous Cell of Head and Neck

Massachusetts

Boston Massachusetts 02215

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Boston Massachusetts 02114

A clinical trial to evaluate treatments using MGA271 for patients

Boston Massachusetts 02215

A clinical trial to evaluate treatments using MGA271 for patients

Boston Massachusetts 02215

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Boston Massachusetts 02114

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Danvers Massachusetts 01923

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Michigan

Kalamazoo Michigan 49007

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

New York

Bronx New York 10461

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Bronx New York 10461

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

New York New York 10029

A clinical research study of ADXS11-001 (ADXS-HPV) for the treatment of Head and Neck Cancer, Squamous Cell Carcinoma of the Head and Neck or Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma

New York New York 10016

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

North Carolina

Chapel Hill North Carolina 27599

A Phase 2 clinical study for patients with Head and Neck Cancer or Squamous Cell Carcinoma of the Head and Neck

Huntersville North Carolina 28078

A clinical trial to evaluate treatments using MGA271 for patients

Oklahoma

Oklahoma City Oklahoma 73104

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Pennsylvania

Philadelphia Pennsylvania 19104

A clinical trial seeking patients for a research study for the treatment of Aerodigestive Malignancies (e.g Squamous Cell Carcinoma)

Philadelphia Pennsylvania 19104

A clinical trial to evaluate treatments using MGA271 for patients

Philadelphia Pennsylvania 19111

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Philadelphia Pennsylvania 19104

A clinical trial to evaluate treatments using TH-4000 for patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin (SCCHN or SCCS)

Philadelphia Pennsylvania 19111

Patients are needed to participate in a clinical research study evaluating Reirradiation and MK-3475 for the treatment of Recurrent Head and Neck Cancer or Carcinoma, Squamous Cell of Head and Neck

Pittsburgh Pennsylvania 15232

A clinical trial seeking patients for a research study for the treatment of Head and Neck Squamous Cell Carcinoma

Pittsburgh Pennsylvania 15224

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Tennessee

Nashville Tennessee 37203

A clinical trial to evaluate treatments using MGA271 for patients

Nashville Tennessee 37203

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Nashville Tennessee 37232

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Nashville Tennessee 37232

A clinical trial to evaluate treatments using TH-4000 for patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin (SCCHN or SCCS)

Texas

Dallas Texas 75390

A clinical trial to evaluate treatments using TH-4000 for patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin (SCCHN or SCCS)

Fort Worth Texas 76177

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating Stereotactic Body Radiotherapy (SABR) for the treatment of Lung Cancer